Defence Therapeutics Inc.: Defence to Complete a Final Pre-Clinical Study Prior to IND Filings for the AccuTOX Phase I Cancer Trial at the City of Hope National Medical Center and Beckman Research Institute
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized